Pseudogout, chondrocalcinosis, CPPD et al: crystal clear… or clear as mud?-The time has come to reconsider the nomenclature of calcium pyrophosphate deposition.

IF 20.6 1区 医学 Q1 RHEUMATOLOGY
Annals of the Rheumatic Diseases Pub Date : 2025-08-01 Epub Date: 2025-05-01 DOI:10.1016/j.ard.2025.04.004
Silvia Sirotti, Charlotte Jauffret, Antonella Adinolfi, Edoardo Cipolletta, Daniele Cirillo, Luca Ingrao, Alessandro Lucia, Emilio Filippucci, Tristan Pascart, Sara K Tedeschi, Robert Terkeltaub, Nicola Dalbeth, Georgios Filippou
{"title":"Pseudogout, chondrocalcinosis, CPPD et al: crystal clear… or clear as mud?-The time has come to reconsider the nomenclature of calcium pyrophosphate deposition.","authors":"Silvia Sirotti, Charlotte Jauffret, Antonella Adinolfi, Edoardo Cipolletta, Daniele Cirillo, Luca Ingrao, Alessandro Lucia, Emilio Filippucci, Tristan Pascart, Sara K Tedeschi, Robert Terkeltaub, Nicola Dalbeth, Georgios Filippou","doi":"10.1016/j.ard.2025.04.004","DOIUrl":null,"url":null,"abstract":"<p><p>Scientific interest in calcium pyrophosphate deposition (CPPD) has been limited by several challenges. These include difficulties in diagnosis due to diverse clinical presentations, the lack of classification criteria, the absence of standardised diagnostic modalities, underrecognition in clinical care, and, most significantly, the lack of evidence-based treatments. Consequently, CPPD was often regarded as the 'poor cousin' of gout. Fortunately, in recent years, CPPD has garnered increased attention from the rheumatology community. Milestones such as the first American College of Rheumatology/European Alliance of Association for Rheumatology classification criteria, the European Alliance of Association for Rheumatology recommendations for the use of imaging in clinical practice, validated OMERACT ultrasound definitions and scoring system, and the OMERACT core domain sets for CPPD have significantly advanced the field. Yet, unresolved issues regarding CPPD nomenclature hold back advancement in both research and clinical practice. The terminology surrounding CPPD remains inconsistent in the scientific literature, with numerous terms and acronyms used to describe the condition and its manifestations. For example, many 'pseudosyndromes' (eg, pseudogout) and purely radiographic descriptors (eg, chondrocalcinosis) are still commonly used by clinicians and researchers interchangeably, as either the name of the condition or one of its clinical or radiographic manifestations. This lack of standardisation complicates communication among health care professionals, researchers, and between doctors and patients, creating insurmountable barriers to effective care and research advances. In this viewpoint, we highlight the value of standardised terminology, drawing parallels with other rheumatic diseases. We aimed to explore the historical evolution of CPPD nomenclature, assess the impact of previous standardisation efforts, and propose a possible way for a common language.</p>","PeriodicalId":8087,"journal":{"name":"Annals of the Rheumatic Diseases","volume":" ","pages":"1287-1292"},"PeriodicalIF":20.6000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of the Rheumatic Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ard.2025.04.004","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/5/1 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Scientific interest in calcium pyrophosphate deposition (CPPD) has been limited by several challenges. These include difficulties in diagnosis due to diverse clinical presentations, the lack of classification criteria, the absence of standardised diagnostic modalities, underrecognition in clinical care, and, most significantly, the lack of evidence-based treatments. Consequently, CPPD was often regarded as the 'poor cousin' of gout. Fortunately, in recent years, CPPD has garnered increased attention from the rheumatology community. Milestones such as the first American College of Rheumatology/European Alliance of Association for Rheumatology classification criteria, the European Alliance of Association for Rheumatology recommendations for the use of imaging in clinical practice, validated OMERACT ultrasound definitions and scoring system, and the OMERACT core domain sets for CPPD have significantly advanced the field. Yet, unresolved issues regarding CPPD nomenclature hold back advancement in both research and clinical practice. The terminology surrounding CPPD remains inconsistent in the scientific literature, with numerous terms and acronyms used to describe the condition and its manifestations. For example, many 'pseudosyndromes' (eg, pseudogout) and purely radiographic descriptors (eg, chondrocalcinosis) are still commonly used by clinicians and researchers interchangeably, as either the name of the condition or one of its clinical or radiographic manifestations. This lack of standardisation complicates communication among health care professionals, researchers, and between doctors and patients, creating insurmountable barriers to effective care and research advances. In this viewpoint, we highlight the value of standardised terminology, drawing parallels with other rheumatic diseases. We aimed to explore the historical evolution of CPPD nomenclature, assess the impact of previous standardisation efforts, and propose a possible way for a common language.

假性骨化症、软骨钙化症、CPPD等:晶莹剔透……还是像泥一样清晰?是时候重新考虑焦磷酸钙沉积的命名了。
焦磷酸钙沉积(CPPD)的科学兴趣受到一些挑战的限制。其中包括由于临床表现不同而导致的诊断困难,缺乏分类标准,缺乏标准化的诊断方式,临床护理中认识不足,最重要的是缺乏循证治疗。因此,CPPD通常被认为是痛风的“穷亲戚”。幸运的是,近年来,CPPD获得了风湿病学界越来越多的关注。诸如第一个美国风湿病学会/欧洲风湿病协会联盟分类标准,欧洲风湿病协会联盟在临床实践中使用成像的建议,验证的OMERACT超声定义和评分系统,以及用于CPPD的OMERACT核心域集等里程碑都显着推动了该领域的发展。然而,关于CPPD命名的未解决的问题阻碍了研究和临床实践的进步。围绕CPPD的术语在科学文献中仍然不一致,有许多术语和缩略语用于描述这种情况及其表现。例如,许多“假综合征”(如假性out)和纯粹的放射学描述符(如软骨钙化症)仍然被临床医生和研究人员互换使用,作为疾病的名称或其临床或放射学表现之一。缺乏标准化使卫生保健专业人员、研究人员之间以及医生和患者之间的沟通复杂化,为有效护理和研究进展造成了不可逾越的障碍。在这一观点中,我们强调标准化术语的价值,并将其与其他风湿病进行比较。我们旨在探讨CPPD命名法的历史演变,评估以往标准化工作的影响,并提出一种可能的通用语言。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Annals of the Rheumatic Diseases
Annals of the Rheumatic Diseases 医学-风湿病学
CiteScore
35.00
自引率
9.90%
发文量
3728
审稿时长
1.4 months
期刊介绍: Annals of the Rheumatic Diseases (ARD) is an international peer-reviewed journal covering all aspects of rheumatology, which includes the full spectrum of musculoskeletal conditions, arthritic disease, and connective tissue disorders. ARD publishes basic, clinical, and translational scientific research, including the most important recommendations for the management of various conditions.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信